Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/article/10.1007/s00345-018-2355-y/fulltext.html
Reference64 articles.
1. Cancer of the Kidney and Renal Pelvis—Cancer Stat Facts. In: Surveill. Epidemiol. End Results SEER Program Natl. Cancer Inst. https://seer.cancer.gov/statfacts/html/kidrp.html . Accessed 15 Dec 2017
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer Oxf Engl 1990 49:1374–1403. https://doi.org/10.1016/j.ejca.2012.12.027
3. Delahunt B, Cheville JC, Martignoni G et al (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37:1490–1504. https://doi.org/10.1097/PAS.0b013e318299f0fb
4. Golshayan AR, George S, Heng DY et al (2009) Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol Off J Am Soc Clin Oncol 27:235–241. https://doi.org/10.1200/JCO.2008.18.0000
5. Molina AM, Tickoo SK, Ishill N et al (2011) Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. Am J Clin Oncol 34:454–459. https://doi.org/10.1097/COC.0b013e3181f47aa4
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Case report: Sarcomatoid renal cell carcinoma masquerading as hydronephrosis;Frontiers in Oncology;2024-05-22
2. Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles;Journal of Clinical Investigation;2024-04-23
3. Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma;Heliyon;2024-04
4. Renal cell carcinoma and venous tumor thrombus: predicting sarcomatoid dedifferentiation through preoperative IVIM-based MR imaging;Abdominal Radiology;2024-02-27
5. Research Progress on First-Line Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma;Advances in Clinical Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3